AI-enabled multi-omics platform using lipidomics and proprietary biomarkers for early cancer detection in women.
GlycoLocate is AOA Dx's foundational AI-enabled cancer detection platform that pioneers the use of lipidomics to unlock next-generation biomarkers for early cancer diagnosis. It combines multi-omics data with data science to deliver insights into early detection, focused on women's health. The platform is designed to be cost-effective and translatable from research into clinical practice. GlycoLocate is a product of AOA Dx.